Clinigen predicts full-year profits boost
Profits at Burton-based Clinigen are expected to rise by 22% for the year-ending 30 June, the firm said this morning (18 July).
The profits hike will be driven by a combination of organic growth across all operations, a full year's contribution from Link Healthcare and currency benefits, says Clinigen.
Shaun Chilton, group chief executive officer of Clinigen Group said: "This has been another excellent year with all three operations, CTS, Unlicensed Medicines and Commercial Medicines, performing strongly.
"We have made signif... You can carry on reading TheBusinessDesk.com for free, but you have reached the maximum number of pages an unregistered user can view. To register for an account, click here or login below...
